secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2024-05-29T23:59:59+00:00
Accession:  0001493152-24-021787
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric Biosciences shareholders elect all six director nominees and approve say-on-pay at 2024 annual meeting
--------------------------------------------------------------------------------

- All six director nominees elected; Michael D. Webb received 767,013 for, 107,751 withheld.
- Say-on-pay proposal approved (711,513 for, 116,232 against); advisory frequency set to one year (774,619 votes).
- Ratification of Marcum LLP as auditor for FY2024 approved (2,485,258 for, 170,212 against).
- Approx. 2.8M shares (38.75% of outstanding) represented, establishing quorum at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315224021787/0001493152-24-021787-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315224021787/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-021787

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer